News | Nuclear Imaging | April 20, 2016

Top U.K. Cancer Center Chooses Mirada Medical Technology

Agreement will bring proton therapy, MR-guided linear accelerators and PET/MR technology to U.K. hospital

Mirada Medical, The Christie Hospital, England, PET-MRI, radiation therapy

April 20, 2016 — Mirada Medical announced a new agreement to work with the clinicians and physicists at The Christie Hospital in Manchester, England, a world-renowned centre for complete cancer care. The Christie is the only U.K. hospital that will be treating cancer patients with proton therapy and magnetic resonance imaging (MRI)-guided linear accelerators (LINAC), whilst benefiting from the latest advancements in diagnostics with positron emission tomography (PET)/MRI.

With Mirada specializing in software to enable collaboration between departments and treatment methods, this is a natural relationship that will support fundamental changes in treatment protocols, reducing time to treatment whilst improving clinical confidence and efficacy.

“We have chosen Mirada as strategic partner to develop multimodality imaging solutions because of the quality of their software, allowing rapid translation of novel techniques into our clinic while also providing the possibility to efficiently integrate workflows for the different treatment techniques that are available at our site,” said Prof. Marcel Van Herk, chair in radiotherapy physics at the University of Manchester and The Christie NHS Foundation Trust.

For more information: www.mirada-medical.com

Related Content

World's largest radiation oncology meeting will offer full conference on interactive platform October 25-28, 2020
News | ASTRO | July 09, 2020
July 9, 2020 — Registration opens today for the American Society for Radiation Oncology's (...
Radiotherapy has been used to treat cancers for more than a century and continues to be utilized in cancer treatment plans today. Since the introduction of radiotherapy, clinicians have been working tirelessly to further refine treatments to better target cancer.
Feature | Radiation Therapy | July 06, 2020 | By Yves Archambault
Everything has room for improvement, right? Right. When it comes to cancer care, it is no different.
Proton therapy has evolved, and future predictions include smaller systems, more sophisticated proton dosimetry and devices that manipulate the proton beam
Feature | Proton Therapy | July 06, 2020 | By Minesh Mehta, M.D.
The field of proton...
News | Proton Therapy | June 16, 2020
June 17, 2020 — RaySearch Laboratories AB launched the latest release of its widely adopted treatment planning system
Vacancy rates for radiation therapists rose substantially since 2018, according to a survey performed this year by the American Society of Radiologic Technologists. Researchers noted, however, the survey data was collected before the COVID-19 pandemic began affecting the surveyed clinical settings.

Getty Images

News | Radiation Therapy | June 05, 2020
June 5, 2020 — Vacancy rates for radiation therapists rose substantially since 2018, according to a survey performed
Nuclear Cardiology Optimistic About Return to Pre-COVID-19 Exam Levels. An American Society of Nuclear Cardiology (ASNC) member survey are confident nuclear cardiology volumes will return to pre-pandemic levels. #COVID19 #SARScov2
News | Nuclear Imaging | June 01, 2020
June 1, 2020 — While acknowledging the challenges their specialty is facing, more than two-thirds of respondents to a